Minnesota House of Representatives bill in Session 2026 Regular.
Status: in_committee. Latest action: April 7, 2026.
A bill for an act relating to health; permitting Formulary Committee members with a potential conflict of interest to participate in committee communications and discussions; requiring the commissioner of human services to develop a public comment process for recommendations to the Formulary Committee; requiring the Formulary Committee to seek expertise from the Minnesota Rare Disease Advisory Council; amending Minnesota Statutes 2024, section 256B.0625, subdivisions 13f, 13g; Minnesota Statutes 2025 Supplement, section 256B.0625, subdivision 13c.
Formulary Committee members with a potential conflict of interest permitted to participate in committee communications and discussions, commissioner of human services required to develop a public comment process for recommendations, and committee required to seek expertise from the Minnesota Rare Disease Advisory Council.
| Date | Event | Detail |
|---|---|---|
| 2026-04-07 | Introduced | Bill introduced |
| 2026-04-07 | Status | in_committee |
| 2026-04-07 | Latest Action | Introduction and first reading, referred to Health Finance and Policy pg. 5616 Intro |